Novartis Investigative Site

Rialto, California 92377

0 studies enrolling now · 3 studies all time

What they study most

Non-alcoholic Steatohepatitis (NASH), Primary Biliary Cholangitis

Studies at this site

• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis — Completed
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early
• A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients — Completed